Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Tumour antigen protein and tumour antigen peptide

A tumor antigen peptide, tumor antigen technology, used in peptide/protein components, anti-tumor drugs, peptide sources, etc., can solve problems such as unsatisfactory prognosis, and achieve the effect of preventing and treating tumor cell metastasis

Inactive Publication Date: 2008-06-11
PEKING UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the treatment of lung cancer is mainly adjuvant treatment methods such as traditional surgical resection and radiotherapy and chemotherapy. However, most patients have entered the middle and late stages when they are diagnosed and have already metastasized when they are discovered, so the prognosis is still not ideal.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tumour antigen protein and tumour antigen peptide
  • Tumour antigen protein and tumour antigen peptide
  • Tumour antigen protein and tumour antigen peptide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1. Discovery of BJ-TSA-9 full-length cDNA in tumor tissue

[0027] According to the data in the Unigene and EST databases in Genbank, using online bioinformatics tools such as SAGE and virtualNortherns, the sequence on chromosome 8 was analyzed, and it was found that the 24th region of the long arm of chromosome 8 may encode a tumor-specific gene. Therefore, specific PCR primers were designed according to its sequence, and the full-length mRNA sequence of BJ-TSA-9 was successfully cloned from lung cancer tissue.

[0028] Firstly, total RNA was extracted from lung cancer and adjacent tissues with TRIzol kit (Gibco Company), and the concentration and purity of mRNA were detected by ultraviolet spectrophotometry. Reverse transcription was performed using the advantage reverse transcriptase kit (Clontech Company), and cDNA was synthesized from 2 μg of total RNA. After diluting to 100ul, take 2.5ul as a template, and perform PCR with high-fidelity pfu DNA synthetase...

Embodiment 2

[0029] Embodiment 2, use the method of RT-PCR to prove the expression situation of BJ-TSA-9 gene in 16 kinds of human normal tissues and lung cancer, intestinal cancer, gastric cancer

[0030] cDNA of 16 commercial human normal tissues from the biotechnology company CLONTECH (spleen, prostate, testis, ovary, small intestine, large intestine, white blood cells, heart, lung, liver, brain, kidney, pancreas, placenta, skeletal muscle, thymus), cDNAs from cancer tissues and matched paracancerous tissues of 40 lung cancer patients, cDNAs from cancer tissues and matched paracancerous tissues of 12 colon cancer patients, cancer tissues and matched cancer tissues of 10 gastric cancer patients The cDNA of adjacent tissues was used to detect the expression of BJ-TSA-9 gene in normal tissues and tumor tissues.

[0031]Conditions for RT-PCR in the present invention: use CLONTECH's advanced hot-start DNA polymerase, 94°C for 20 seconds; 64°C for 30 seconds; 72°C for 1 minute and 30 seconds,...

Embodiment 3

[0032] Embodiment 3, Northern blot hybridization to analyze the expression of BJ-TSA-9 gene in lung cancer tumor tissue

[0033] Use TRIZOL reagent (PROMEGA) to extract total RNA from the cancer tissue and paired paracancerous tissues of lung cancer patients, denature 20ug of total RNA in the presence of formamide and formaldehyde, perform agarose electrophoresis, and transfer to Hybond-N+nylon membrane (Amersham) and fixed by UV crosslinking. Use Digoxigenin DNA Probe Labeling Kit (ROCHE) to label the DNA fragments amplified in Example 2 to make DNA probes, hybridize with tRNA on the membrane according to the conventional Northern hybridization method, and then perform autoradiography , the mRNA of the tumor-specific antigen protein gene BJ-TSA-9 in the present invention was detected. Then, boil the membrane used to detect the gene mRNA in 1% SDS solution, remove the digoxin-labeled probe, use the labeled housekeeping gene G3PDH as a probe, and use the same method to perform...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A tumor antigen protein and its tumor antigen peptide used to prepare the medicine for treating lung cancer are disclosed. Said tumor antigen protein can generate the peptide fragment by cell endolysis. Said peptide fragment can bind with the (MHC)-I molecular compatible with main tissue and can be recognized by T cells. The DNA sequence coding said tumor antigen protein has the nucleotide sequence No.AF497803 in GenBank.

Description

technical field [0001] The invention relates to a tumor-specific antigen protein and tumor antigen peptide, in particular to a tumor antigen protein and tumor antigen peptide for treating lung cancer. Background technique [0002] As a new mode of tumor treatment, tumor biotherapy has gradually become an irreplaceable and important part of comprehensive tumor treatment, which mainly includes two aspects of immunotherapy and gene therapy. Based on the analysis of current international research trends and from the perspective of practical application, it is speculated that tumor immunotherapy will have broad application prospects. The traditional method is to vaccinate patients with tumor cells, tumor extracts or certain components as antigens, and achieve the purpose of controlling tumors by stimulating immune responses. However, in the absence of identifiable tumor-specific antigens, the elicited nonspecific immune activity is limited in controlling tumor growth. [0003] ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/435C07K14/47C12N15/12A61K38/17A61K39/00A61P35/00
Inventor 陈慰峰李云燕尹艳慧董学员苏艳荣
Owner PEKING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com